These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study. Ananda Kumar CS; Kavitha CV; Vinaya K; Benaka Prasad SB; Thimmegowda NR; Chandrappa S; Raghavan SC; Rangappa KS Invest New Drugs; 2009 Aug; 27(4):327-37. PubMed ID: 18839066 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. Ananda Kumar CS; Benaka Prasad SB; Vinaya K; Chandrappa S; Thimmegowda NR; Kumar YC; Swarup S; Rangappa KS Eur J Med Chem; 2009 Mar; 44(3):1223-9. PubMed ID: 18973966 [TBL] [Abstract][Full Text] [Related]
4. Hydantoin derivatives of L- and D-amino acids: synthesis and evaluation of their antiviral and antitumoral activity. Rajic Z; Zorc B; Raic-Malic S; Ester K; Kralj M; Pavelic K; Balzarini J; De Clercq E; Mintas M Molecules; 2006 Nov; 11(11):837-48. PubMed ID: 18007390 [TBL] [Abstract][Full Text] [Related]
5. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Zuliani V; Carmi C; Rivara M; Fantini M; Lodola A; Vacondio F; Bordi F; Plazzi PV; Cavazzoni A; Galetti M; Alfieri RR; Petronini PG; Mor M Eur J Med Chem; 2009 Sep; 44(9):3471-9. PubMed ID: 19268405 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study. Benaka Prasad SB; Vinaya K; Ananda Kumar CS; Swarup S; Rangappa KS Invest New Drugs; 2009 Dec; 27(6):534-42. PubMed ID: 19066725 [TBL] [Abstract][Full Text] [Related]
7. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor. Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Chandrappa S; Benaka Prasad SB; Vinaya K; Ananda Kumar CS; Thimmegowda NR; Rangappa KS Invest New Drugs; 2008 Oct; 26(5):437-44. PubMed ID: 18473120 [TBL] [Abstract][Full Text] [Related]
9. QSAR characterization of new synthesized hydantoins with antiproliferative activity. Tot K; Lazić A; Božić B; Mandić A; Djaković Sekulić T Biomed Chromatogr; 2019 Aug; 33(8):e4539. PubMed ID: 30927290 [TBL] [Abstract][Full Text] [Related]
10. Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line. Obradović A; Matić M; Ognjanović B; Vuković N; Vukić M; Đurđević P; Ušćumlić G; Božić B; Nedeljković BB Anticancer Agents Med Chem; 2019; 19(12):1491-1502. PubMed ID: 31840594 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents. Zhang M; Liang YR; Li H; Liu MM; Wang Y Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741 [TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative Activities of Some Bivalent Symmetrical 5-Substituted Hydantoin Derivatives towards Human Brain Glioma U251 Cells (U251) and Human Carcinoma Cells (KB3-1). Furutachi M; Ota K; Fujisaki F; Ikeda R; Yoshikawa N; Yokota T; Takeda Y; Yokomizo K; Zhou JR; Kashige N; Miake F; Sumoto K Biol Pharm Bull; 2019; 42(11):1953-1956. PubMed ID: 31685778 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids. Shankaraiah N; Nekkanti S; Chudasama KJ; Senwar KR; Sharma P; Jeengar MK; Naidu VG; Srinivasulu V; Srinivasulu G; Kamal A Bioorg Med Chem Lett; 2014 Dec; 24(23):5413-7. PubMed ID: 25453799 [TBL] [Abstract][Full Text] [Related]
14. 5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. Carmi C; Cavazzoni A; Zuliani V; Lodola A; Bordi F; Plazzi PV; Alfieri RR; Petronini PG; Mor M Bioorg Med Chem Lett; 2006 Aug; 16(15):4021-5. PubMed ID: 16713265 [TBL] [Abstract][Full Text] [Related]
15. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins. Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of 5-arylidene aromatic derivatives of hydantoin. Part 2. Szymańska E; Kieć-Kononowicz K; Białecka A; Kasprowicz A Farmaco; 2002 Jan; 57(1):39-44. PubMed ID: 11902644 [TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade. Gerona-Navarro G; González-Muñiz R; Fernández-Carvajal A; González-Ros JM; Ferrer-Montiel A; Carreño C; Albericio F; Royo M ACS Comb Sci; 2011 Sep; 13(5):458-65. PubMed ID: 21671576 [TBL] [Abstract][Full Text] [Related]
19. Study on the Synthesis, Characterization and Bioactivities of 3-Methyl-9'-fluorenespiro-5-hydantoin. Marinova P; Marinov M; Kazakova M; Feodorova Y; Slavchev A; Blazheva D; Georgiev D; Penchev P; Sarafian V; Stoyanov N Acta Chim Slov; 2016; 63(1):26-32. PubMed ID: 26970785 [TBL] [Abstract][Full Text] [Related]
20. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation. Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]